The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An international cohort study investigating the impact of age on clinical outcome in patients with hepatocellular carcinoma treated with sorafenib.
 
Rohini Sharma
No Relationships to Disclose
 
Saur Hajiev
No Relationships to Disclose
 
Leila Motedayan Aval
No Relationships to Disclose
 
Dominik Bettinger
No Relationships to Disclose
 
Tadaaki Arizumi
No Relationships to Disclose
 
Mario Pirisi
No Relationships to Disclose
 
Lorenza Rimassa
Honoraria - Abbvie; Amgen; AstraZeneca; Eisai; Gilead Sciences; Ipsen; Lilly; Roche; Sanofi
Consulting or Advisory Role - Amgen; ArQule; Basilea; Baxter; Bayer; Celgene; Eisai; Exelixis; Hengrui Therapeutics; Incyte; Ipsen; Italfarmaco; Lilly; Merck Sharp & Dohme; Roche; Sanofi; Sirtex Medical
Research Funding - Agios (Inst); ARMO BioSciences (Inst); ArQule (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Eisai (Inst); Exelixis (Inst); Exelixis/Ipsen (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - ArQule; Ipsen
 
Nicola Personeni
No Relationships to Disclose
 
Tiziana Pressiani
No Relationships to Disclose
 
Laura Giordano
No Relationships to Disclose
 
Masatoshi Kudo
Honoraria - Bayer; Eisai; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; MSD; Ono Pharmaceutical
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Robert Thimme
No Relationships to Disclose
 
Joong-Won Park
No Relationships to Disclose
 
Tamar Hamosh Taddei
No Relationships to Disclose
 
David Edward Kaplan
Honoraria - Bayer
Consulting or Advisory Role - Exelixis
Research Funding - Bayer (Inst); Gilead Sciences (Inst); Inovio Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Glypican-3 Chimeric Antigen Receptor (Inst)
 
Ramya Ramaswami
No Relationships to Disclose
 
David James Pinato
Consulting or Advisory Role - Eisai; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb
 
Elias Allara
No Relationships to Disclose